Advertisement
UK markets close in 7 hours 21 minutes
  • FTSE 100

    8,081.91
    +37.10 (+0.46%)
     
  • FTSE 250

    19,808.45
    +8.73 (+0.04%)
     
  • AIM

    756.32
    +1.45 (+0.19%)
     
  • GBP/EUR

    1.1630
    +0.0002 (+0.01%)
     
  • GBP/USD

    1.2435
    -0.0017 (-0.14%)
     
  • Bitcoin GBP

    53,589.44
    +393.57 (+0.74%)
     
  • CMC Crypto 200

    1,435.98
    +11.88 (+0.83%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CRUDE OIL

    83.39
    +0.03 (+0.04%)
     
  • GOLD FUTURES

    2,333.80
    -8.30 (-0.35%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,169.83
    +340.90 (+2.03%)
     
  • DAX

    18,214.76
    +77.11 (+0.43%)
     
  • CAC 40

    8,116.04
    +10.26 (+0.13%)
     

Nano-X Imaging Ltd.'s (NASDAQ:NNOX) Profit Outlook

With the business potentially at an important milestone, we thought we'd take a closer look at Nano-X Imaging Ltd.'s (NASDAQ:NNOX) future prospects. Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The US$902m market-cap company announced a latest loss of US$113m on 31 December 2022 for its most recent financial year result. Many investors are wondering about the rate at which Nano-X Imaging will turn a profit, with the big question being “when will the company breakeven?” We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate.

Check out our latest analysis for Nano-X Imaging

Consensus from 2 of the American Medical Equipment analysts is that Nano-X Imaging is on the verge of breakeven. They expect the company to post a final loss in 2024, before turning a profit of US$36m in 2025. The company is therefore projected to breakeven around 2 years from today. In order to meet this breakeven date, we calculated the rate at which the company must grow year-on-year. It turns out an average annual growth rate of 70% is expected, which is extremely buoyant. Should the business grow at a slower rate, it will become profitable at a later date than expected.

earnings-per-share-growth
earnings-per-share-growth

Underlying developments driving Nano-X Imaging's growth isn’t the focus of this broad overview, though, bear in mind that typically a high growth rate is not out of the ordinary, particularly when a company is in a period of investment.

ADVERTISEMENT

One thing we’d like to point out is that The company has managed its capital prudently, with debt making up 1.6% of equity. This means that it has predominantly funded its operations from equity capital, and its low debt obligation reduces the risk around investing in the loss-making company.

Next Steps:

There are key fundamentals of Nano-X Imaging which are not covered in this article, but we must stress again that this is merely a basic overview. For a more comprehensive look at Nano-X Imaging, take a look at Nano-X Imaging's company page on Simply Wall St. We've also put together a list of essential aspects you should look at:

  1. Historical Track Record: What has Nano-X Imaging's performance been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.

  2. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Nano-X Imaging's board and the CEO’s background.

  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here